Point of care testing to monitor INR control in patients with antiphospholipid syndrome
{{output}}
Patients with antiphospholipid syndrome (APS) typically require lifelong warfarin anticoagulation following a thrombotic event due to a significant risk of recurrent thrombosis. Point of care testing (POCT) to monitor INR is discouraged in patients with APS as... ...
